Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for SeaStar Medical Holding (ICU) over the last 3 years, with Q2 2025 value amounting to -$16000.0.

  • SeaStar Medical Holding's Gains from Investment Securities rose 9914.89% to -$16000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$108000.0, marking a year-over-year decrease of 10536.51%. This contributed to the annual value of $697000.0 for FY2024, which is 22788.99% up from last year.
  • As of Q2 2025, SeaStar Medical Holding's Gains from Investment Securities stood at -$16000.0, which was up 9914.89% from -$16000.0 recorded in Q1 2025.
  • SeaStar Medical Holding's 5-year Gains from Investment Securities high stood at $2.8 million for Q1 2024, and its period low was -$1.9 million during Q2 2024.
  • In the last 3 years, SeaStar Medical Holding's Gains from Investment Securities had a median value of -$56000.0 in 2023 and averaged $12100.0.
  • Examining YoY changes over the last 5 years, SeaStar Medical Holding's Gains from Investment Securities showed a top increase of 800555.56% in 2024 and a maximum decrease of 16002.77% in 2024.
  • Quarter analysis of 3 years shows SeaStar Medical Holding's Gains from Investment Securities stood at $1.2 million in 2023, then tumbled by 106.13% to -$76000.0 in 2024, then surged by 78.95% to -$16000.0 in 2025.
  • Its Gains from Investment Securities was -$16000.0 in Q2 2025, compared to -$16000.0 in Q1 2025 and -$76000.0 in Q4 2024.